Liver Transplantation at Mayo Clinic Florida.
David D. Lee, Kristopher P. Croome, Dana K. Perry, Justin M.
Burns, Justin H. Nguyen, Andrew P. Keaveny, and C. Burcin Taner
Clinical Transplants 2014, Chapter 10
Abstract
Over the sixteen year history of liver transplantation (LT)
at Mayo Clinic in Jacksonville, Florida (MCF), we have maintained a practice
devoted to excellence in pre- and post-LT management for patients suffering
from end stage liver disease. With an emphasis on quality, MCF has made several
adjustments with the goal of better utilizing marginal grafts for both
successful post-transplant outcomes and minimizing waitlist mortality. This
systematic approach is most exemplified in our experience with donation after
cardiac death (DCD) liver allografts. Understanding the events during
procurement has been critical to reducing the complications associated with
donor warm ischemia time that are unique to DCD allografts. Better matching of
donors to recipients has helped identify patients who are safe to receive more
marginal grafts with successful patient and graft survival. Recognizing the
spectrum of degree of sickness in patients undergoing LT, we implemented a
multidisciplinary approach that allows for the avoidance of the intensive care
unit after LT. In these ways, MCF continues to distinguish itself as an
innovator in the field of transplantation for the benefit of continued better
care for our patients suffering from end stage liver disease.
Liver Transplantation at Mayo Clinic Florida
- Product Code: CT14_Ch10
- Availability: In Stock
-
$5.00